290 related articles for article (PubMed ID: 27129149)
1. IAP antagonists sensitize murine osteosarcoma cells to killing by TNFα.
Shekhar TM; Miles MA; Gupte A; Taylor S; Tascone B; Walkley CR; Hawkins CJ
Oncotarget; 2016 Jun; 7(23):33866-86. PubMed ID: 27129149
[TBL] [Abstract][Full Text] [Related]
2. Smac mimetics LCL161 and GDC-0152 inhibit osteosarcoma growth and metastasis in mice.
Shekhar TM; Burvenich IJG; Harris MA; Rigopoulos A; Zanker D; Spurling A; Parker BS; Walkley CR; Scott AM; Hawkins CJ
BMC Cancer; 2019 Sep; 19(1):924. PubMed ID: 31521127
[TBL] [Abstract][Full Text] [Related]
3. Smac mimetics in combination with TRAIL selectively target cancer stem cells in nasopharyngeal carcinoma.
Wu MS; Wang GF; Zhao ZQ; Liang Y; Wang HB; Wu MY; Min P; Chen LZ; Feng QS; Bei JX; Zeng YX; Yang D
Mol Cancer Ther; 2013 Sep; 12(9):1728-37. PubMed ID: 23699656
[TBL] [Abstract][Full Text] [Related]
4. LCL161 increases paclitaxel-induced apoptosis by degrading cIAP1 and cIAP2 in NSCLC.
Yang C; Wang H; Zhang B; Chen Y; Zhang Y; Sun X; Xiao G; Nan K; Ren H; Qin S
J Exp Clin Cancer Res; 2016 Sep; 35(1):158. PubMed ID: 27737687
[TBL] [Abstract][Full Text] [Related]
5. Smac mimetics can provoke lytic cell death that is neither apoptotic nor necroptotic.
Miles MA; Caruso S; Baxter AA; Poon IKH; Hawkins CJ
Apoptosis; 2020 Aug; 25(7-8):500-518. PubMed ID: 32440848
[TBL] [Abstract][Full Text] [Related]
6. cIAP1 and cIAP2 limit macrophage necroptosis by inhibiting Rip1 and Rip3 activation.
McComb S; Cheung HH; Korneluk RG; Wang S; Krishnan L; Sad S
Cell Death Differ; 2012 Nov; 19(11):1791-801. PubMed ID: 22576661
[TBL] [Abstract][Full Text] [Related]
7. USP11-dependent selective cIAP2 deubiquitylation and stabilization determine sensitivity to Smac mimetics.
Lee EW; Seong D; Seo J; Jeong M; Lee HK; Song J
Cell Death Differ; 2015 Sep; 22(9):1463-76. PubMed ID: 25613375
[TBL] [Abstract][Full Text] [Related]
8. SMAC Mimetics Induce Autophagy-Dependent Apoptosis of HIV-1-Infected Resting Memory CD4+ T Cells.
Campbell GR; Bruckman RS; Chu YL; Trout RN; Spector SA
Cell Host Microbe; 2018 Nov; 24(5):689-702.e7. PubMed ID: 30344003
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential and molecular mechanism of a novel, potent, nonpeptide, Smac mimetic SM-164 in combination with TRAIL for cancer treatment.
Lu J; McEachern D; Sun H; Bai L; Peng Y; Qiu S; Miller R; Liao J; Yi H; Liu M; Bellail A; Hao C; Sun SY; Ting AT; Wang S
Mol Cancer Ther; 2011 May; 10(5):902-14. PubMed ID: 21372226
[TBL] [Abstract][Full Text] [Related]
10. Inhibitor of Apoptosis Protein-1 Regulates Tumor Necrosis Factor-Mediated Destruction of Intestinal Epithelial Cells.
Grabinger T; Bode KJ; Demgenski J; Seitz C; Delgado ME; Kostadinova F; Reinhold C; Etemadi N; Wilhelm S; Schweinlin M; Hänggi K; Knop J; Hauck C; Walles H; Silke J; Wajant H; Nachbur U; W Wei-Lynn W; Brunner T
Gastroenterology; 2017 Mar; 152(4):867-879. PubMed ID: 27889570
[TBL] [Abstract][Full Text] [Related]
11. Key necroptotic proteins are required for Smac mimetic-mediated sensitization of cholangiocarcinoma cells to TNF-α and chemotherapeutic gemcitabine-induced necroptosis.
Akara-Amornthum P; Lomphithak T; Choksi S; Tohtong R; Jitkaew S
PLoS One; 2020; 15(1):e0227454. PubMed ID: 31914150
[TBL] [Abstract][Full Text] [Related]
12. Small-molecule IAP antagonists sensitize cancer cells to TRAIL-induced apoptosis: roles of XIAP and cIAPs.
Finlay D; Vamos M; González-López M; Ardecky RJ; Ganji SR; Yuan H; Su Y; Cooley TR; Hauser CT; Welsh K; Reed JC; Cosford ND; Vuori K
Mol Cancer Ther; 2014 Jan; 13(1):5-15. PubMed ID: 24194568
[TBL] [Abstract][Full Text] [Related]
13. Anticancer agents sensitize osteosarcoma cells to TNF-related apoptosis-inducing ligand downmodulating IAP family proteins.
Mirandola P; Sponzilli I; Gobbi G; Marmiroli S; Rinaldi L; Binazzi R; Piccari GG; Ramazzotti G; Gaboardi GC; Cocco L; Vitale M
Int J Oncol; 2006 Jan; 28(1):127-33. PubMed ID: 16327988
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor‑related apoptosis‑inducing ligand as a therapeutic option in urothelial cancer cells with acquired resistance against first‑line chemotherapy.
Vallo S; Stege H; Berg M; Michaelis M; Winkelmann R; Rothweiler F; Cinatl J
Oncol Rep; 2020 Apr; 43(4):1331-1337. PubMed ID: 32020226
[TBL] [Abstract][Full Text] [Related]
15. The smac mimetic LCL161 targets established pulmonary osteosarcoma metastases in mice.
Harris MA; Shekhar TM; Miles MA; Cerra C; Hawkins CJ
Clin Exp Metastasis; 2021 Oct; 38(5):441-449. PubMed ID: 34398333
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Bcl-2 or IAP proteins does not provoke mutations in surviving cells.
Shekhar TM; Green MM; Rayner DM; Miles MA; Cutts SM; Hawkins CJ
Mutat Res; 2015 Jul; 777():23-32. PubMed ID: 25916945
[TBL] [Abstract][Full Text] [Related]
17. IAP antagonists Birinapant and AT-406 efficiently synergise with either TRAIL, BRAF, or BCL-2 inhibitors to sensitise BRAFV600E colorectal tumour cells to apoptosis.
Perimenis P; Galaris A; Voulgari A; Prassa M; Pintzas A
BMC Cancer; 2016 Aug; 16():624. PubMed ID: 27520705
[TBL] [Abstract][Full Text] [Related]
18. Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism.
Allensworth JL; Sauer SJ; Lyerly HK; Morse MA; Devi GR
Breast Cancer Res Treat; 2013 Jan; 137(2):359-71. PubMed ID: 23225169
[TBL] [Abstract][Full Text] [Related]
19. RIP1 protein-dependent assembly of a cytosolic cell death complex is required for inhibitor of apoptosis (IAP) inhibitor-mediated sensitization to lexatumumab-induced apoptosis.
Basit F; Humphreys R; Fulda S
J Biol Chem; 2012 Nov; 287(46):38767-77. PubMed ID: 22927431
[TBL] [Abstract][Full Text] [Related]
20. Inhibitor of Apoptosis Proteins Determines Glioblastoma Stem-Like Cell Fate in an Oxygen-Dependent Manner.
Soubéran A; Cappaï J; Chocry M; Nuccio C; Raujol J; Colin C; Lafitte D; Kovacic H; Quillien V; Baeza-Kallee N; Rougon G; Figarella-Branger D; Tchoghandjian A
Stem Cells; 2019 Jun; 37(6):731-742. PubMed ID: 30920104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]